Action Petros Pharmaceuticals (PK) - PTPI

Petros Pharmaceuticals Inc (PK) (PTPI) Action

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

Dernier

0,0062

( 12,73% )

Prix Achat

0,0055

Prix Vente

0,0069

Volume échangé

24 730

0,0056 Fourchette du Jour 0,0069

0,0017 Plage de 52 semaines 0,04

Cap du marché

262,164k

Clôture Veille

0,0055

Ouverture

0,0069

Dernière Transaction

2684

0.0062

Dernière heure de transaction

Volume financier

US$ 157

VWAP

0,006357

Volume moyen (3 m)

US$ 104 994

Actions en circulation

42 284 502

Rendement du Dividende (LTM)

Ratio Cours sur Bénéfices

-0,01

Bénéfice par action (BPA)

-0,87

Chiffre d'affairess (LTM)

Bénéfice net (LTM)

3,19M

Petros Pharmaceuticals, Inc., a healthcare technology company, focuses on developing and licensing proprietary software as a service (SaaS) platform and Software as a medical device web application designed to assist pharmaceutical companies. The company is based in New York, New York. Petros Pharmaceuticals, Inc., a healthcare technology company, focuses on developing and licensing proprietary software as a service (SaaS) platform and Software as a medical device web application designed to assist pharmaceutical companies. The company is based in New York, New York.

Secteur

Healthcare

Industrie

Pharmaceuticals

Site Web

petrospharma.com

Siège social

New York, United States

Fondé

Petros Pharmaceuticals Inc (PK) est coté dans le secteur Healthcare de la OTC Markets avec le ticker PTPI. Le dernier cours de clôture d'Petros Pharmaceuticals (PK) était de US$0,01. Au cours de la dernière année, les actions de Petros Pharmaceuticals (PK) ont été négociées dans une fourchette de prix de US$ 0,0017 à US$ 0,04.

Petros Pharmaceuticals (PK) compte actuellement 42 284 502 actions en circulation. La capitalisation boursière d'Petros Pharmaceuticals (PK) est de US$262 163,91 . Petros Pharmaceuticals (PK) a un ratio cours/bénéfice (ratio PE) de -0.01.

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	-0.0002	-3.125	0.0064	0.007	0.005	80578	0.0057658	CS
4	-0.0015	-19.4805194805	0.0077	0.0079	0.005	74663	0.00639096	CS
12	-0.001	-13.8888888889	0.0072	0.01	0.005	103957	0.00662428	CS
26	-0.0052	-45.6140350877	0.0114	0.0158	0.0017	133505	0.00810927	CS
52	-0.0258	-80.625	0.032	0.04	0.0017	253571	0.02214237	CS
156	-0.0164	-72.5663716814	0.0226	0.06	0.0017	322760	0.02685374	CS
260	-0.0164	-72.5663716814	0.0226	0.06	0.0017	322760	0.02685374	CS

PTPI - Frequently Asked Questions (FAQ)

What is the current Petros Pharmaceuticals Inc (PK) share price?

The current share price of Petros Pharmaceuticals Inc (PK) is US$ 0,0062

How many Petros Pharmaceuticals Inc (PK) shares are in issue?

Petros Pharmaceuticals Inc (PK) has 42 284 502 shares in issue

What is the market cap of Petros Pharmaceuticals Inc (PK)?

The market capitalisation of Petros Pharmaceuticals Inc (PK) is USD 262,16k

What is the 1 year trading range for Petros Pharmaceuticals Inc (PK) share price?

Petros Pharmaceuticals Inc (PK) has traded in the range of US$ 0,0017 to US$ 0,04 during the past year

What is the PE ratio of Petros Pharmaceuticals Inc (PK)?

The price to earnings ratio of Petros Pharmaceuticals Inc (PK) is -0,01

What is the registered address of Petros Pharmaceuticals Inc (PK)?

The registered address for Petros Pharmaceuticals Inc (PK) is 1185 Avenue of the Americas, New York, New York, 10036

What is the Petros Pharmaceuticals Inc (PK) website address?

The website address for Petros Pharmaceuticals Inc (PK) is petrospharma.com

Which industry sector does Petros Pharmaceuticals Inc (PK) operate in?

Petros Pharmaceuticals Inc (PK) operates in the Pharmaceuticals sector

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Petros Pharmaceuticals Inc (PK) (PTPI)

Petros Pharmaceuticals Inc (PK) (PTPI) Action

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

À propos de Petros Pharmaceuticals Inc (PK)

PTPI Dernières nouvelles

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Form 8-K - Current report

PTPI - Frequently Asked Questions (FAQ)

PTPI Transactions

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Pourquoi rejoindre ADVFN?

Tout ce dont les traders professionnels ont besoin.

Supprimer les publicités